Skip to main content
IQV
NYSE Life Sciences

IQVIA Stock Plunges 11.8% on Missed EPS Guidance Despite Revenue Beat

feedReported by Wiseek News
Sentiment info
Negative
Importance info
9
Price
$176.71
Mkt Cap
$29.988B
52W Low
$134.645
52W High
$247.045
Market data snapshot near publication time

summarizeSummary

IQVIA Holdings reported quarterly revenue of $4.36 billion, a 10.3% year-over-year increase that surpassed analyst forecasts. However, the company's stock price dropped a significant 11.8% after missing its earnings per share (EPS) guidance. This immediate market reaction indicates that the profitability miss is a material concern for investors, outweighing the positive revenue performance and a recent analyst upgrade to 'Overweight' by Barclays. This quarterly update provides a critical, more recent financial snapshot following the company's annual 10-K filing in February for fiscal year 2025. Traders will be closely monitoring management's commentary on the factors behind the EPS miss and any potential adjustments to future guidance.

At the time of this announcement, IQV was trading at $176.71 on NYSE in the Life Sciences sector, with a market capitalization of approximately $30B. The 52-week trading range was $134.65 to $247.05. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed IQV - Latest Insights

IQV
Apr 23, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
IQV
Mar 06, 2026, 3:03 PM EST
Source: Wiseek News
Importance Score:
9
IQV
Feb 27, 2026, 4:52 PM EST
Filing Type: DEF 14A
Importance Score:
7
IQV
Feb 17, 2026, 7:46 AM EST
Filing Type: 10-K
Importance Score:
7
IQV
Feb 05, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
7